Wilson's Disease Treated With D-Penicillamine: Characterization of Skin Damage Secondary to Treatment by Measuring Skin Elasticity

Recruiting N/A Interventional Study
Wilson Disease D-Penicillamine Effect of D-penicilline on Cutaneous Elastity of Wilson's Patient
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
12 and older
Sex
Any
Study type
Interventional
Purpose
Supportive Care
Participants needed
120 (estimated)
Sponsor
Centre Hospitalier Universitaire de Saint Etienne · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Wilson's disease is a genetic disorder, resulting from an anomaly present on the ATP7B gene located on chromosome 13, causing a progressive accumulation of copper in various organs such as the liver, nervous system and cornea, leading to various hepatic and neurological disorders and a systemic evolution. Currently, the first-line treatment for this disease is D-Penicillamine, which acts by chela…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: Diseased patients : * Patient over 12 years old * Patient with Wilson's disease confirmed by genetic analysis * Patient followed up in the Wilson's Disease Reference Center for his care * Patient treated with D-Penicillamine * Patient with no other known elastic tissue patholog…
Contacts

Jean Luc PERROT, PHD

(0)4 77 82 83 33

j.luc.perrot@chu-st-etienne.fr

CONTACT

Eduardo COUCHONNAL-BEDOYA, MD

(0)4 72 35 70 50

CONTACT